247 related articles for article (PubMed ID: 12227390)
1. Challenging the current treatment paradigm for methicillin-resistant Staphylococcus epidermidis peritonitis in peritoneal dialysis patients.
Ariano RE; Franczuk C; Fine A; Harding GK; Zelenitsky SA
Perit Dial Int; 2002; 22(3):335-8. PubMed ID: 12227390
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases.
Govindarajulu S; Hawley CM; McDonald SP; Brown FG; Rosman JB; Wiggins KJ; Bannister KM; Johnson DW
Perit Dial Int; 2010; 30(3):311-9. PubMed ID: 20190031
[TBL] [Abstract][Full Text] [Related]
3. Coagulase-negative staphylococcal peritonitis: outcomes of cephalosporin-resistant strains.
Heywood A; Bargman JM
Adv Perit Dial; 2010; 26():34-6. PubMed ID: 21348376
[TBL] [Abstract][Full Text] [Related]
4. A 12-month review of peritoneal dialysis-related peritonitis in Western Australia: is empiric vancomycin still indicated for some patients?
Kan GW; Thomas MA; Heath CH
Perit Dial Int; 2003; 23(5):465-8. PubMed ID: 14604199
[TBL] [Abstract][Full Text] [Related]
5. Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients.
Khairullah Q; Provenzano R; Tayeb J; Ahmad A; Balakrishnan R; Morrison L
Perit Dial Int; 2002; 22(3):339-44. PubMed ID: 12227391
[TBL] [Abstract][Full Text] [Related]
6. Should cefazolin or vancomycin be used for initial empiric coverage for Staphylococcus aureus in peritoneal dialysis associated peritonitis?
Hansson JH
Semin Dial; 2011; 24(4):449-50. PubMed ID: 21851410
[No Abstract] [Full Text] [Related]
7. Treatment and outcome of peritonitis in automated peritoneal dialysis, using a once-daily cefazolin-based regimen.
Fielding RE; Clemenger M; Goldberg L; Brown EA
Perit Dial Int; 2002; 22(3):345-9. PubMed ID: 12227392
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy.
Sieradzki K; Roberts RB; Serur D; Hargrave J; Tomasz A
J Clin Microbiol; 1999 Jan; 37(1):39-44. PubMed ID: 9854061
[TBL] [Abstract][Full Text] [Related]
9. Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center.
Oliveira LG; Luengo J; Caramori JC; Montelli AC; Cunha Mde L; Barretti P
Int Urol Nephrol; 2012 Oct; 44(5):1529-37. PubMed ID: 22302733
[TBL] [Abstract][Full Text] [Related]
10. Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases.
Szeto CC; Kwan BC; Chow KM; Lau MF; Law MC; Chung KY; Leung CB; Li PK
Clin J Am Soc Nephrol; 2008 Jan; 3(1):91-7. PubMed ID: 18032790
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a synthetic antimicrobial peptidomimetic versus vancomycin in a Staphylococcus epidermidis device-related murine peritonitis model.
Cavanagh JP; Granslo HN; Fredheim EA; Christophersen L; Jensen PØ; Thomsen K; Van Gennip M; Klingenberg C; Flaegstad T; Moser C
J Antimicrob Chemother; 2013 Sep; 68(9):2106-10. PubMed ID: 23645587
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin-resistant enterococcus infection is a rare complication in patients receiving PD on an outpatient basis.
Ng R; Zabetakis PM; Callahan C; Krapf R; Sasak C; Fritzsch S; Pollock A; Balter P; Michelis MF
Perit Dial Int; 1999; 19(3):273-4. PubMed ID: 10433167
[No Abstract] [Full Text] [Related]
13. Initial treatment of CAPD peritonitis: poor response with association of cefazolin and amikacin.
Onozato ML; Caramori JC; Barretti P
Perit Dial Int; 1999; 19(1):88-9. PubMed ID: 10201353
[No Abstract] [Full Text] [Related]
14. Treatment in PD patients of peritonitis caused by gram-positive organisms with single daily dose of antibiotics.
Vas S; Bargman J; Oreopoulos D
Perit Dial Int; 1997; 17(1):91-4. PubMed ID: 9068032
[No Abstract] [Full Text] [Related]
15. Treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) with intraperitoneal cefazolin and gentamicin.
Weber J; Staerz E; Mettang T; Machleidt C; Kuhlmann U
Perit Dial Int; 1989; 9(3):191-5. PubMed ID: 2488364
[TBL] [Abstract][Full Text] [Related]
16. Peritonitis in peritoneal dialysis patients in Uruguay.
Gadola L; Orihuela L; Pérez D; Gómez T; Solá L; Chifflet L; Mautone M; Torres E; Rodriguez G
Perit Dial Int; 2008; 28(3):232-5. PubMed ID: 18474913
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a non-vancomycin-based peritoneal dialysis peritonitis protocol.
Toussaint N; Mullins K; Snider J; Murphy B; Langham R; Gock H
Nephrology (Carlton); 2005 Apr; 10(2):142-6. PubMed ID: 15877673
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of
Htay H; Cho Y; Pascoe EM; Darssan D; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW
Perit Dial Int; 2017; 37(6):619-626. PubMed ID: 28698253
[TBL] [Abstract][Full Text] [Related]
19. Ampicillin-sulbactam and amikacin used as second-line antibiotics for patients with culture-negative peritonitis.
Lam MF; Tang BS; Tse KC; Chan TM; Lai KN
Perit Dial Int; 2008; 28(5):540-2. PubMed ID: 18708550
[No Abstract] [Full Text] [Related]
20. Efficacy of vancomycin plus tobramycin as antiperitonitis regimen for patients on CAPD.
Vargemezis V; Thodis E; Pasadakis P; Martinis G; Kousta E
Adv Perit Dial; 1990; 6():123-5. PubMed ID: 1982788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
